Our work on antitubercular agents led to the identification of BM 212 as a lead compound among a series of pyrrole derivatives with good in vitro activity against mycobacteria and candidae. Further studies led us to synthesize additional pyrroles bearing the thiomorpholinomethyl moiety and different aryl substituents at N1 and C5. Some of them revealed very active, prompting us to design the new pyrrole derivatives 5-20 in the hope of increasing the activity and better understanding the influence of ortho halogens on the antimycobacterial activity. Microbiological data showed interesting in vitro activity toward Myeobacterium tuberculosis and atypical mycobacteria. (C) 2004 Elsevier Ltd. All rights reserved.

Antimycobacterial compounds. Optimization of the BM 212 structure, the lead compound for a new pyrrole derivative class / Biava, Mariangela; Porretta, Giulio Cesare; Poce, Giovanna; Delia, Deidda; Raffaello, Pompei; Andrea, Tafi; Fabrizio, Manetti. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - STAMPA. - 13:4(2005), pp. 1221-1230. [10.1016/j.bmc.2004.11.018]

Antimycobacterial compounds. Optimization of the BM 212 structure, the lead compound for a new pyrrole derivative class

BIAVA, Mariangela;PORRETTA, Giulio Cesare;POCE, Giovanna;
2005

Abstract

Our work on antitubercular agents led to the identification of BM 212 as a lead compound among a series of pyrrole derivatives with good in vitro activity against mycobacteria and candidae. Further studies led us to synthesize additional pyrroles bearing the thiomorpholinomethyl moiety and different aryl substituents at N1 and C5. Some of them revealed very active, prompting us to design the new pyrrole derivatives 5-20 in the hope of increasing the activity and better understanding the influence of ortho halogens on the antimycobacterial activity. Microbiological data showed interesting in vitro activity toward Myeobacterium tuberculosis and atypical mycobacteria. (C) 2004 Elsevier Ltd. All rights reserved.
2005
antimycobacterial activity; pharmacophore model; pyrrole derivatives; thiomorpholinomethyl substituent
01 Pubblicazione su rivista::01a Articolo in rivista
Antimycobacterial compounds. Optimization of the BM 212 structure, the lead compound for a new pyrrole derivative class / Biava, Mariangela; Porretta, Giulio Cesare; Poce, Giovanna; Delia, Deidda; Raffaello, Pompei; Andrea, Tafi; Fabrizio, Manetti. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - STAMPA. - 13:4(2005), pp. 1221-1230. [10.1016/j.bmc.2004.11.018]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/365959
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 62
  • ???jsp.display-item.citation.isi??? 57
social impact